Research highlights that there are currently no effective low-side-effect drugs for acute lung injury.
Isochlorogenic acid A shows potential in reducing inflammation, oxidative stress, and pulmonary edema caused by LPS in acute lung injury.
This compound also prevents cell apoptosis and inhibits key signaling pathways, suggesting it could be a strong candidate for future treatments of acute lung injury.